ISRCTN48342048已完成不适用
Hormonal and metabolic effects of diet and exercise programs in obese women with polycystic ovary syndrome : a prospective randomised controlled trial
Karolinska Institute (Sweden)0 个研究点目标入组 45 人开始时间: 2011年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Women aged 18-40 years diagnosed with PCOS and having body mass index (BMI) > 27
排除标准
- •1. The presence of other disease or a different endocrine disorder
- •2. An eating disorder
- •3. Smoking
- •4. Continuous medication including insulin sensitising drugs
研究者
相似试验
已完成
不适用
Hormonal and metabolic effects of diet and physical activity in women with polycystic ovary syndrome (PCOS)Polycystic ovary syndrome (PCOS)Pregnancy and ChildbirthISRCTN18400086Karolinska Institutet50
已完成
不适用
se of insulin sensitisers to revert metabolic syndromeISRCTN58810841Hospital Sant Joan de Deu (Spain)52
进行中（未招募）
1 期
Diet, physical exercise, and metabolic control intervention to reduce the incidence of major neurocognitive disorders among individuals with type 2 diabetes combined with mild neurocognitive impairment – a pilot studyType 2 diabetesEUCTR2019-003772-39-SEmeå University80
已完成
不适用
Aerobic Exercise With Diet Induces Hormonal, Metabolic, and Psychological ChangesDepressionElderlyHormonesInsulin ResistanceNCT05136742Cairo University60
进行中（未招募）
不适用
Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism and Cardiovascular Risk - Pioglitazone in PCOSPolycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat excess and/or impaired insulin sensitivity. These cytokines -together with other indices of low-grade inflammation-, sucj as C-reactive protein (CRP), and the neutrophil count, contribute to link insulin-resistant states with cardiovascular disease risks.EUCTR2005-004163-39-ESHospital Sant Joan de Déu40